Filing Flows › Quanterix (QTRX) › Q2 2025
Quanterix (QTRX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Quanterix (QTRX) reported revenue of $24.5M for the second quarter 2025 (Q2 2025), -29% from a year earlier and -19% from the quarter before. Operating margin was -151.6%, net loss $30.0M (122.6% of revenue).
Quanterix, Q2 2025: revenue $24.5M (-29% year over year), operating margin -151.6%, net loss $30.0M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.5M | -19% | -29% |
| Operating profit | −$37.1M | — | — |
| Net earnings | −$30.0M | — | — |
| Operating cash flow | −$5.7M | — | — |
What changed
Revenue was $24.5M in Q2 2025, down 29% year over year and down 19% from the previous quarter. Consumable and other products was the largest line at 61% of revenue. Research services lost $6.1M year over year (down 60%), 62% of the total change.
Gross margin was 46.2%, down 18.5 points from a year earlier. Operating costs exceeded revenue by $37.1M, an operating margin of -151.6%. Operating expenses grew 46% against a revenue fall of 29%. The fastest-growing cost line was Other operating costs (+868%). The quarter ended with a net loss of $30.0M, wider than the previous quarter's $20.5M loss. Non-operating items added $7.0M, -23% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$5.7M. Non-cash charges added back $2.0M of depreciation and amortization and $5.4M of share-based compensation. Working capital and other items added $17.0M. Capital expenditures of $777K exceeded it, leaving free cash flow of −$6.4M.
Questions
What was Quanterix's revenue in the second quarter 2025?
Quanterix (QTRX) reported revenue of $24.5M for the second quarter 2025 (Q2 2025), -29% from a year earlier and -19% from the quarter before.
Was Quanterix profitable in the second quarter 2025?
Operating loss was $37.1M (-151.6% of revenue) and net loss $30.0M.
Source: Quanterix 10-Q on SEC EDGAR.